Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Else Sandset , Jesse Dawson , Urs Fischer , et al Added: 1 year ago
Dr Else Sandset (Oslo University Hospital, NO) is joined by Prof Jesse Dawson (University of Glasgow, GB), Dr Urs Fischer (University Hospital Basel, CH) and Dr Masatoshi Koga (National Cerebral and Cardiovascular Center, JP) to discuss the findings from their recent paper on "Early versus Later Anticoagulation for Stroke with Atrial Fibrillation" published in the New England Journal of Medicine… View more
Author(s): Thorsten Hanke Added: 8 months ago
First presented at ESC 2024, this on-demand programme sees Prof Gregory Lip(University of Liverpool, UK) lead a faculty comprisingProf Elena Arbelo (University of Barcelona, ES), ProfThorsten Hanke(Asklepios Klinikum Harburg, DE) andProf Richard Whitlock(McMaster University, CA) review the application of the latest AF guidance in a clinical setting.This case-based programme explores the… View more
Start date: Sep 01, 2024 End date: Sep 01, 2024
Radcliffe Medical Education is hosting a symposium entitled 'AF Stroke Prevention: Applying New Guidance in the Real World' at 15:15 UTC+1 on Sunday 1 September 2024 in Dublin Room atESC 2024, ExCel Centre, London, UK.Add to your calendar.OverviewProf Gregory Lip(University of Liverpool, Liverpool, UK) will lead a faculty comprisingProf Elena Arbelo (University of Barcelona, ES), ProfThorsten… View more
Author(s): William McIntyre Added: 1 year ago
EHRA 24 - Investigator, Dr William McIntyre (Population Health Research Institute, CA) joins us to discuss the findings from a substudy of ARTESiA (NCT01938248).ARTESiA was a randomized, parallel assignment clinical trial which aimed to assess if apixaban could reduce the risk of ischemic stroke and systemic embolism in patients with subclinical atrial fibrillation (AF) and additional risk… View more
Author(s): Naima Maqsood , Jeff Healey Added: 1 year ago
AHA 2023 — Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews investigator, Dr Jeff Healey (McMaster University, CA) to outline the findings from a phase 4 trial of apixaban to reduce thromboembolism in patients with subclinical atrial fibrillation (AF).ARTESiA (NCT01938248) aims to determine if apixaban in combination with aspirin can reduce the instance of… View more
Author(s): Valentina Kutyifa Added: 3 weeks ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of… View more
Author(s): Gerhard Hindricks , Faizel Osman , Keitaro Senoo , et al Added: 1 year ago
This video series page covers content associated with Atrial Fibrillation.AFib is associated with a 5x greater risk of stroke, however with effective treatment, the risk of stroke can be reduced.¹ The lifetime risk for AFib is 1 in 3 individuals² and it often occurs with hypertension. Early detection is key, to allow for prompt and satisfactory disease management to not only control symptoms but… View more
Author(s): Renato D Lopes Added: 8 months ago
ESC Congress 24 — AF screening with a wearable ECG device increases diagnosis by over 50% but did not significantly reduce hospitalisation rates for stroke.We are joined onsite at ESC Congress 2024 by Dr Renato Lopes (Duke University Medical Center, NC) to discuss the findings from the GUARD-AF Trial (NCT04126486, Bristol-Myers Squibb), which was designed to determine if screening for undiagnosed… View more
Author(s): Dipak Kotecha Added: 8 months ago
ESC Congress 2024 — Improved patient-level adherence to guideline recommendations on heart rhythm control through healthcare professional education in patients with atrial fibrillation.Investigator, Dr Dipak Kotecha (University of Birmingham, UK) joins us in London to share key findings from the STEEER-AF study (NCT04396418).This prospective, cluster-randomized international study compared two… View more